Policy

Latest News

May 3rd 2016

Costs and Spillover Effects of Private Insurers' Coverage of Hepatitis C Treatment

By Gigi A. Moreno, PhD, Karen Mulligan, PhD, Caroline Huber, MPH

Expanding private-payer coverage of hepatitis C treatment may yield significant long-term cost savings for private payers, reduced costs to Medicare, and increased social value.

CME Content

On-Demand Virtual Symposium

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

On-Demand Virtual Symposium

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

On-Demand Webinar

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

1.0 Credit / Psychiatry

Virtual Symposium

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology

On-Demand Webinar

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

1.5 Credit / Pain Management/Opioids

On-Demand Webinar

Overview and Burden of Migraine

0.5 Credit / Neurology

On-Demand Webinar

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology

On-Demand Webinar

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology

On-Demand Webinar

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

On-Demand Webinar

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

1.0 Credit / Oncology, Hematology, Hematologic Cancer

Online Article

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

On-Demand Virtual Symposium

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

On-Demand Virtual Symposium

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

On-Demand Virtual Symposium

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

1.5 Credits / HIV/AIDS, Infectious Disease

On-Demand Virtual Symposium

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

1.5 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Virtual Symposium

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology

On-Demand Virtual Symposium

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

1.5 Credits / Psychiatry

On-Demand Virtual Symposium

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

1.5 Credits / Women's Health

On-Demand Virtual Symposium

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology

On-Demand Virtual Symposium

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

On-Demand Virtual Symposium

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry

On-Demand Virtual Symposium

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases

On-Demand Virtual Symposium

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

On-Demand Virtual Symposium

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology

On-Demand Virtual Symposium

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

On-Demand Virtual Symposium

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

1.5 Credits / Immunology

On-Demand Virtual Symposium

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

On-Demand Virtual Symposium

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology

On-Demand Webinar

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

On-Demand Webinar

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

1.0 Credit / Pain Management/Opioids

On-Demand Webinar

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology

On-Demand Webinar

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

2.0 Credits / Pain Management/Opioids

Coverage for Hepatitis C Drugs in Medicare Part D

ByJeah Kyoungrae Jung, PhD,Roger Feldman, PhD,Chelim Cheong, PhD,Ping Du, MD, PhD,Douglas Leslie, PhD

May 3rd 2016

This study analyzes the current coverage designs for hepatitis C virus drugs by Medicare Part D plans.

Experts Share Final Thoughts on Delivering Better Value-Based Care in Oncology

April 29th 2016

Need for Stakeholder Participation in Developing Payment Models

April 29th 2016

Is a Single-Payer System the Answer to Our Healthcare Woes?

April 29th 2016

Impact of Consolidation on the Value of Care Delivery

April 29th 2016

Limitations of ICER's Value Assessment Framework Tool

April 29th 2016

Evidence Blocks: Patient Versus Societal Costs

April 29th 2016

The ASCO Value Framework as a Tool for Shared Decision Making

April 29th 2016

Using the DrugAbacus Value Calculator

April 29th 2016

The NCCN Evidence Blocks

April 29th 2016

Can Oncologists Perceive the Value of a Treatment?

April 29th 2016

Filling the Data Gaps, Improving Patient Understanding

April 29th 2016

Data Fragmentation: A Barrier to Value Constructs

April 29th 2016

Evaluating the Quality of Evidence Used for Developing Value Frameworks

April 29th 2016

Rightsizing Drug Distribution to Improve Value

April 29th 2016

How Do Payers Balance Personalized Care With Population Health?

April 29th 2016

Cost Implications of Oncology Care for the Patient

April 29th 2016

Value Equation: Do Patients and Oncologists Agree?

April 29th 2016

Eliminating Data Silos to Benefit the Patient

April 29th 2016

Understanding the Drug Developer's Perception of Value

April 29th 2016

Arguing for the Patient as the Consumer of Healthcare

April 29th 2016

Can Patients Distinguish Volume From Value in Healthcare?

April 29th 2016

Stakeholders Define Value in Healthcare

April 29th 2016

Assessing the Impact of an Integrated Care System on the Healthcare Expenditures of Children With Special Healthcare Needs

ByMircea I. Marcu, PhD,Caprice A. Knapp, PhD,David Brown, PhD,Vanessa L. Madden, BSc,Hua Wang, MS

April 19th 2016

This study analyzes the effect of a managed care program on Medicaid expenditures for children with special healthcare needs using a quasi-experimental design.

Lost in Translation: Healthcare Utilization by Low-Income Workers Receiving Employer-Sponsored Health Insurance

ByBruce W. Sherman, MD,Wendy D. Lynch, PhD,Carol Addy, MD, MMSc

April 15th 2016

An opportunity exists to better understand healthcare utilization patterns by low-income workers, which may contribute significantly to employer healthcare cost trend and lost workforce productivity.

Policy

Latest News

CME Content

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

Coverage for Hepatitis C Drugs in Medicare Part D

Experts Share Final Thoughts on Delivering Better Value-Based Care in Oncology

Need for Stakeholder Participation in Developing Payment Models

Is a Single-Payer System the Answer to Our Healthcare Woes?

Impact of Consolidation on the Value of Care Delivery

Limitations of ICER's Value Assessment Framework Tool

Evidence Blocks: Patient Versus Societal Costs

The ASCO Value Framework as a Tool for Shared Decision Making

Using the DrugAbacus Value Calculator

The NCCN Evidence Blocks

Can Oncologists Perceive the Value of a Treatment?

Filling the Data Gaps, Improving Patient Understanding

Data Fragmentation: A Barrier to Value Constructs

Evaluating the Quality of Evidence Used for Developing Value Frameworks

Rightsizing Drug Distribution to Improve Value

How Do Payers Balance Personalized Care With Population Health?

Cost Implications of Oncology Care for the Patient

Value Equation: Do Patients and Oncologists Agree?

Eliminating Data Silos to Benefit the Patient

Understanding the Drug Developer's Perception of Value

Arguing for the Patient as the Consumer of Healthcare

Can Patients Distinguish Volume From Value in Healthcare?

Stakeholders Define Value in Healthcare

Assessing the Impact of an Integrated Care System on the Healthcare Expenditures of Children With Special Healthcare Needs

Lost in Translation: Healthcare Utilization by Low-Income Workers Receiving Employer-Sponsored Health Insurance

Trending on AJMC

Withdrawal of Aid Could Cause Millions of Lives Lost to HIV

EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy

Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color

FDA Approves Second Generic Mifepristone Pill for Abortion

5 Reasons Why Bariatric Surgery May Beat GLP-1s for Weight Loss